The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback